Marco M. E. Vogel

826 total citations
32 papers, 420 citations indexed

About

Marco M. E. Vogel is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and General Health Professions. According to data from OpenAlex, Marco M. E. Vogel has authored 32 papers receiving a total of 420 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pulmonary and Respiratory Medicine, 9 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in General Health Professions. Recurrent topics in Marco M. E. Vogel's work include Prostate Cancer Treatment and Research (15 papers), Prostate Cancer Diagnosis and Treatment (11 papers) and Radiopharmaceutical Chemistry and Applications (7 papers). Marco M. E. Vogel is often cited by papers focused on Prostate Cancer Treatment and Research (15 papers), Prostate Cancer Diagnosis and Treatment (11 papers) and Radiopharmaceutical Chemistry and Applications (7 papers). Marco M. E. Vogel collaborates with scholars based in Germany, Switzerland and Italy. Marco M. E. Vogel's co-authors include Stephanie E. Combs, Kerstin A. Kessel, Friederike Schmidt‐Graf, H. Bier, Stephanie E. Combs, Matthias Eiber, Jürgen E. Gschwend, Markus Oechsner, Ulrich Keller and Christian Peschel and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Marco M. E. Vogel

32 papers receiving 416 citations

Peers

Marco M. E. Vogel

PRM

GHP

ONCOL

RNMI

RADIA

T. Lizée France

Corinne Tillier Netherlands

Tzy-Mey Kuo United States

J.W.H. Leer Netherlands

Sewit Teckie United States

Jaesung Heo South Korea

Lia C.G. Verhoef Netherlands

Tiziana Magnani Italy

Carol McPherson United States

Netty Kinsella United Kingdom

T. Lizée France

Marco M. E. Vogel

154 ×0.9

PRM

85 ×0.8

GHP

306 ×3.0

ONCOL

42 ×0.4

RNMI

48 ×0.8

RADIA

Citations per year, relative to Marco M. E. Vogel Marco M. E. Vogel (= 1×) peers T. Lizée

Countries citing papers authored by Marco M. E. Vogel

Since Specialization

Citations

This map shows the geographic impact of Marco M. E. Vogel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco M. E. Vogel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco M. E. Vogel more than expected).

Fields of papers citing papers by Marco M. E. Vogel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco M. E. Vogel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco M. E. Vogel. The network helps show where Marco M. E. Vogel may publish in the future.

Co-authorship network of co-authors of Marco M. E. Vogel

This figure shows the co-authorship network connecting the top 25 collaborators of Marco M. E. Vogel. A scholar is included among the top collaborators of Marco M. E. Vogel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco M. E. Vogel. Marco M. E. Vogel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vogel, Marco M. E., Isabel Rauscher, Jürgen E. Gschwend, et al.. (2025). Biochemical failure-free survival of 18F-rhPSMA-7 and 18F-flotufolastat PET-guided salvage radiotherapy for patients with recurrent prostate cancer. Scientific Reports. 15(1). 2234–2234. 1 indexed citations

Janssen, Stefan, Rami A. El Shafie, Daniel Buergy, et al.. (2023). Mobile applications in radiation oncology—current choices and future potentials. Strahlentherapie und Onkologie. 199(4). 337–349. 3 indexed citations

Zamboglou, Constantinos, Armelle Arnoux, Iosif Strouthos, et al.. (2023). Development and validation of a multi-institutional nomogram of outcomes for PSMA-PET–based salvage radiotherapy in recurrent prostate cancer.. Journal of Clinical Oncology. 41(6_suppl). 355–355. 1 indexed citations

Vogel, Marco M. E., Denise Bernhardt, Stefan Münch, et al.. (2023). Radiotherapy concepts for spinal metastases—results from an online survey among radiation oncologists of the German Society for Radiation Oncology. Strahlentherapie und Onkologie. 200(2). 159–174. 4 indexed citations

Fischer, Julius, Kai J. Borm, Marco M. E. Vogel, et al.. (2021). Evaluation of practical experiences of German speaking radiation oncologists in combining radiation therapy with checkpoint blockade. Scientific Reports. 11(1). 7624–7624. 5 indexed citations

Vogel, Marco M. E., et al.. (2021). Patterns of care for prostate cancer radiotherapy—results from a survey among German-speaking radiation oncologists. Strahlentherapie und Onkologie. 197(11). 962–970. 5 indexed citations

Oechsner, Markus, et al.. (2021). Analysis of using high-precision radiotherapy in the treatment of liver metastases regarding toxicity and survival. BMC Cancer. 21(1). 780–780. 8 indexed citations

Vogel, Marco M. E., Michal Devečka, Jürgen E. Gschwend, et al.. (2021). Feasibility and Outcome of PSMA-PET-Based Dose-Escalated Salvage Radiotherapy Versus Conventional Salvage Radiotherapy for Patients With Recurrent Prostate Cancer. Frontiers in Oncology. 11. 715020–715020. 9 indexed citations

Kirste, Simon, Stephanie Kroeze, Christoph Henkenberens, et al.. (2021). Combining 68Ga-PSMA-PET/CT-Directed and Elective Radiation Therapy Improves Outcome in Oligorecurrent Prostate Cancer: A Retrospective Multicenter Study. Frontiers in Oncology. 11. 640467–640467. 10 indexed citations

10.

Kroeze, Stephanie, Nina-Sophie Schmidt-Hegemann, Marco M. E. Vogel, et al.. (2020). Efficacy of PSMA ligand PET-based radiotherapy for recurrent prostate cancer after radical prostatectomy and salvage radiotherapy. BMC Cancer. 20(1). 362–362. 16 indexed citations

11.

Vogel, Marco M. E., Stephanie Kroeze, Christoph Henkenberens, et al.. (2020). Prognostic risk classification for biochemical relapse-free survival in patients with oligorecurrent prostate cancer after [68Ga]PSMA-PET-guided metastasis-directed therapy. European Journal of Nuclear Medicine and Molecular Imaging. 47(10). 2328–2338. 12 indexed citations

12.

Schiller, Kilian, Kai J. Borm, Michal Devečka, et al.. (2020). PSMA-PET/CT–based Lymph Node Atlas for Prostate Cancer Patients Recurring After Primary Treatment: Clinical Implications for Salvage Radiation Therapy. European Urology Oncology. 4(1). 73–83. 23 indexed citations

13.

Kessel, Kerstin A., et al.. (2020). Single-institutional outcome-analysis of low-dose stereotactic body radiation therapy (SBRT) of adrenal gland metastases. BMC Cancer. 20(1). 536–536. 11 indexed citations

14.

Vogel, Marco M. E., Kerstin A. Kessel, Kilian Schiller, et al.. (2019). Adjuvant versus early salvage radiotherapy: outcome of patients with prostate cancer treated with postoperative radiotherapy after radical prostatectomy. Radiation Oncology. 14(1). 198–198. 4 indexed citations

15.

Vogel, Marco M. E., Kerstin A. Kessel, Jürgen E. Gschwend, et al.. (2018). Early and late toxicity profiles of patients receiving immediate postoperative radiotherapy versus salvage radiotherapy for prostate cancer after prostatectomy. Strahlentherapie und Onkologie. 195(2). 131–144. 5 indexed citations

16.

Kessel, Kerstin A., Marco M. E. Vogel, H. Bier, et al.. (2018). Cancer clinical trials – Survey evaluating patient participation and acceptance in a university-based Comprehensive Cancer Center (CCC). Clinical and Translational Radiation Oncology. 13. 44–49. 5 indexed citations

17.

Kessel, Kerstin A., Marco M. E. Vogel, H. Bier, et al.. (2017). Mobile Health in Oncology: A Patient Survey About App-Assisted Cancer Care. JMIR mhealth and uhealth. 5(6). e81–e81. 82 indexed citations

18.

Vogel, Marco M. E., Stephanie E. Combs, & Kerstin A. Kessel. (2017). mHealth and Application Technology Supporting Clinical Trials: Today’s Limitations and Future Perspective of smartRCTs. Frontiers in Oncology. 7. 37–37. 17 indexed citations

19.

Kessel, Kerstin A., Marco M. E. Vogel, Friederike Schmidt‐Graf, & Stephanie E. Combs. (2016). Mobile Apps in Oncology: A Survey on Health Care Professionals’ Attitude Toward Telemedicine, mHealth, and Oncological Apps. Journal of Medical Internet Research. 18(11). e312–e312. 60 indexed citations

20.

Kessel, Kerstin A., Marco M. E. Vogel, Markus Oechsner, et al.. (2016). Fractionated vs. single-fraction stereotactic radiotherapy in patients with vestibular schwannoma. Strahlentherapie und Onkologie. 193(3). 192–199. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact